Global diabetes cases on pace to soar to 1.3 billion people in the next...
The number of people living with diabetes worldwide is on pace to more than double in the next three decades, for a total of...
Marijuana use linked to surprising genetic changes, new study finds
Marijuana is becoming increasingly popular and legal in various parts of the United States.
According to recent data, about 18% of all Americans have tried...
How chronic pain might lead to dementia
Having a headache or an aching back occasionally is a common part of life. However, for some people, pain isn't just an occasional visitor.
It...
Muscle supplement could help battle Alzheimer’s, study finds
A team of researchers at RUSH recently discovered that a popular muscle-building supplement might also be a potent weapon against Alzheimer's disease.
The supplement, known...
Research shows better high blood pressure treatment for stroke patients
A new study from the University of Georgia suggests that aggressive treatment of high blood pressure in stroke patients might lead to more harm...
High blood pressure drugs may help treat liver diseases
In life, sometimes things go hand in hand.
It appears that this is true for liver disease too. In the world of medicine, we have...
Scientists find the key to managing heart disease
Over 20 million people in the U.S. suffer from chronic coronary disease (CCD), a cluster of long-term heart conditions resulting from inadequate blood flow...
The secret disease in Mona Lisa and a new hope
Do you know the Mona Lisa? It's a famous painting by Leonardo da Vinci, and pretty much everyone knows her smile.
But did you know...
Why so blue? Sugar may shrink brain’s grey matter and cause depression
Depression isn't just a feeling of being a little bit down. It's a serious health issue that affects millions of people all over the...
Alzheimer’s drug donanemab has been hailed as a ‘turning point’ for treatment. But what...
Trial results of a new drug to treat Alzheimer’s disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed...